We get a chance to hear from Loren Mell of UCSD as he discusses the results of HN004, the role and timing of immunotherapy in head and neck cancer, and his thoughts on dose de-escalation in HPV driven oropharyngeal cancer. Don't miss this ASTRO 2022 interview.
We get a chance to hear from Loren Mell of UCSD as he discusses the results of HN004, the role and timing of immunotherapy in head and neck cancer, and his thoughts on dose de-escalation in HPV driven oropharyngeal cancer. Don't miss this ASTRO 2022 interview.